Olatorepatide

CAT: 0804-HY-P10591Size: 1 EachDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-P10591Size:1 Each

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Olatorepatide (Olatorepatidum) is a dual gastric inhibitory polypeptide (GIP) receptor and glucagon like peptide 1 (GLP-1) receptor agonist, with antidiabetic effect[1].

CAS Number

2675496-01-0

Product Name Alternative

Olatorepatidum

UNSPSC

12352209

Target

GLP Receptor; Insulin Receptor

Type

Peptides

Related Pathways

GPCR/G Protein; Protein Tyrosine Kinase/RTK

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/olatorepatide.html

Smiles

O=C([C@@H](N)CC1=CC=C(O)C=C1)NC(C)(C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(NCC(N2[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N3[C@H](C(N4[C@H](C(N5[C@H](C(N[C@H](C(N[C@H](C(N)=O)CCCCNC(COCCOCCNC(COCCOCCNC(CC[C@H](NC(CCCCCCCCCCCCCCCCCCC(O)=O)=O)C(O)=O)=O)=O)=O)=O)CO)=O)CCC5)=O)CCC4)=O)CCC3)=O)C)=O)=O)CO)=O)CO)=O)CCC2)=O)=O)=O)C)=O)CC(C)C)=O)CC(C)C)=O)CC6=CNC7=CC=CC=C67)=O)CC(N)=O)=O)C(C)C)=O)CC8=CC=CC=C8)=O)CCC(O)=O)=O)CCC(N)=O)=O)C)=O)C)=O)[C@H](CC)C)=O)CCCCN)=O)CCC(O)=O)=O)CC(C)C)=O)CC9=CC=C(O)C=C9)=O)[C@H](CC)C)=O)CO)=O)CC%10=CC=C(O)C=C%10)=O)CC(O)=O)=O)CO)=O)[C@@H](C)O)=O)CC%11=CC=CC=C%11)=O)[C@@H](C)O)=O)=O)CCC(O)=O)=O)C

Molecular Formula

C235H357N49O72

Molecular Weight

5020.63

References & Citations

[1]Olatorepatidum (Olatorepatide) . WHO Drug Information, Vol. 37, No. 4, 2023.

Shipping Conditions

Room temperature

Scientific Category

Peptides

Clinical Information

No Development Reported

Alternative Products

Catalog	Name
TP2916-01	Olatorepatide

Olatorepatide

Alternative Products

Popular Products